EARLY IS GOOD INC.
Multi-omic diagnostic platform analyzing DNA, RNA, and protein from a single sample for cancer detection and clinical decision-making
- Sector
- Medtech
- Headquarters
- MUNCIE, IN
- Founded
- 2022
- Latest Form D
- $1.5M, Nov 2022
- Total capital
- $3.2M
- Federal grants
- $1.7M
- 2 awards · 2024–2025
- Rank in peer group#40 of 79
- Private capital raised
- $1.5M
- 1 Form D · last Nov 2022
- 48 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 11 pending · first 2023
- Rank in peer group#19 of 79
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Multiplex and multi-omic diagnostic test for bladder cancer recurrence$830K
- Federal grantHealth and Human S · Phase II · Multiplex and multi-omic diagnostic test for bladder cancer recurrence$822K
- Private capital raisedForm D · SEC · 1st filing$1.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 79 peers
Line = medianMedtech · Instrument
- Federal grants#40 · top 51%
- Granted patents#19 · top 24%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Habarakada Liyanage Thakshila Udayakanthi LiyanageExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 12- PendingAnalyte Detection And QuantificationUSPTOApplication 19110396
- PendingMulti-Omic Integration PlatformUSPTOApplication 18988772
- PendingFiber ArraysUSPTOApplication 18174463
Show all 12 patent records
- Analyte Detection And QuantificationApr 2, 2026 · Application 19110396Pending
- Multi-Omic Integration PlatformJun 26, 2025 · Application 18988772Pending
- Fiber ArraysSep 19, 2024 · Application 18174463Pending
- Cartridge And System For Detecting An Analyte In A Bodily Fluid Sample At Point-of-care BiosensingDec 19, 2023 · US 11,846,599Granted
- Multi-Omic Integration PlatformApplication 63575570Pending
- Fiber ArraysApplication PCTUS2024016883Pending
- Multi-Omic Integration PlatformApplication 63613004Pending
- Analyte Detection And QuantificationApplication PCTUS2023074376Pending
- Analyte Detection And QuantificationApplication 63448134Pending
- Multi-omic Integration PlatformApplication 63704465Pending
- Analyte Detection And QuantificationApplication 63407417Pending
- Multi-omic Integration PlatformApplication PCTUS2024061195Pending
Related companies, and why
- POWELL MANSFIELD, INC.Similar federal contract value in Medtech · null in contracts
- MELLITUS, LLCSimilar federal contract value in Medtech · null in contracts
- HELIXBIND, INC.Similar federal contract value in Medtech · null in contracts
- REVBIO, INC.Similar federal contract value in Medtech · null in contracts
- ENDOMEDIX, INC.Similar federal contract value in Medtech · null in contracts
- PHAST CORPSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .